Five New Genes That Affect Risk Of Developing Coronary Artery Disease (CAD) And Heart Attacks Discovered

Friday, September 23rd, 2011

According to an investigation set to be published in the open-access journal PLoS Genetics, an international group of investigators report the findings of five new genes that affect risk of developing coronary artery disease (CAD) and heart attacks. The investigation was funded by the British Heart Foundation and the National ...

Cryotherapy Or Salicylic Acid Treatment Of Verrucae Equally As Effective

Thursday, September 22nd, 2011

In a project funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA), researchers discovered that there is no evidence of a difference in clearance rates between patient self-treatment for verrucae (A type of wart) and treatment received by healthcare professionals. Verrucae are common, infectious and sometimes ...

NICE Approval Of Mepact (Mifamurtide) For Treating Osteosarcoma Welcomed By Physicians And Patient Groups, UK

Wednesday, September 7th, 2011

Physicians and patient groups welcome the National Institute for Health and Clinical Excellence (NICE) decision to reverse the draft guidance and approve the use of use of Mepact® in their latest appraisal, announced Takeda UK. Mepact® is designed to treat high-grade non-metastatic osteosarcoma in children, adolescents and young adults aged ...

NICE Recommends Golimumab For The Treatment Of Psoriatic Arthritis

Wednesday, April 27th, 2011

The National Institute for Health and Clinical Excellence (NICE) has today issued final guidance recommending golimumab (Simponi) for the treatment of psoriatic arthritis. Golimumab joins a list of treatment options already recommended by NICE for this condition. The guidance recommends golimumab as an option for treating active and progressive psoriatic ...

NICE Consults On Use Of Scanner That Helps Improve Burns Treatment

Sunday, December 12th, 2010

The National Institute for Health and Clinical Excellence (NICE) has opened its consultation on the use a scanner that can help improve how burns are treated. The draft guidance from the new NICE medical technologies programme provisionally supports the use of moorLDI2-BI, a blood flow imaging device which can help ...